57612-65-4

Upstream product

• 1201-31-6 2,3,4,5-tetrafluorobenzoic acid 
• 74-88-4 methyl iodide 
• 125290-70-2 2-(2,3,4,5-tetrafluoro-6-methylphenyl)-4,4-dimethyl-2-oxazoline 
• 90619-70-8 2-(pentafluorophenyl)-4,4-dimethyl-2-oxazoline 

Downstream Products

• 119916-22-2 3,4,6-trifluoro-2-methylbenzoic acid 
• 1310112-66-3 dodecylene bis(4-azido-2,3,5-trifluoro-6-methylbenzoate) 
• 1310112-65-2 C₁₈H₁₂F₆N₈O₂ 
• 1310112-80-1 C₁₈H₁₂F₈N₂O₂ 
• 119915-48-9 2,3,4,5-tetrafluoro-6-methylbenzoyl chloride 
• 119915-88-7 1-(2,4-difluorophenyl)-6,7,8-trifluoro-1,4-dihydro-5-methyl-4-oxo-3-quinolinecarboxylic acid 
• 119915-51-4 ethyl α-(ethoxymethylene)-2,3,4,5-tetrafluoro-6-methyl-β-oxobenzenepropanoate 
• 119915-50-3 ethyl 2,3,4,5-tetrafluoro-6-methyl-β-oxobenzenepropanoate 

Relevant academic research and scientific papers

CROSS-LINKING MOIETY

A cross-linking moiety having a general formula I: N3—ArF—W, wherein ArF comprises a fluorinated phenyl azide group having at least one non-fluorine substituent that is bulkier than fluorine at a meta position relative to

Antibacterial agents

Novel naphthyridine-, and quinolinecarboxylic acids as antibacterial agents are described as well as methods for their manufacture, formulation, and use in treating bacterial infections including the description of certain novel intermediates used in the